Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00845923 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia
A Phase 2 study, sponsored by Winston Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT00845923 is a Phase 2 study that has completed, run by Winston Laboratories. The registered enrollment target is 22 participants.
The verdict
NCT00845923, a Phase 2 study, has completed, sponsored by Winston Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
This proof of concept study is designed to evaluate the safety and efficacy of topically administered Civamide Patch for the treatment of moderate to severe daily pain associated with postherpetic neuralgia localized to the trunk, and with localized post-incisional neuropathic pain syndromes on the trunk.
Interventions
- DRUG Civamide Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00845923
The ClinicalTrials.gov registry entry for NCT00845923 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winston Laboratories, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Civamide Patch is the first listed.
NCT00845923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00845923 about?
NCT00845923 is a clinical study titled "Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia". This proof of concept study is designed to evaluate the safety and efficacy of topically administered Civamide Patch for the treatment of moderate to severe daily pain associated with postherpetic neuralgia localized to the trunk, and with localized post-incisional neuropathic pain syndromes on the ...
What is the current status of trial NCT00845923?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2009-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00845923?
The interventions under investigation include: Civamide Patch (DRUG).
Who is sponsoring clinical trial NCT00845923?
This trial is sponsored by Winston Laboratories, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.